Johnson & Johnson
Drugmakers including Johnson & Johnson on Tuesday denied claims they helped fuel the deadly opioid epidemic in the United States through deceptive marketing that downplayed addiction risks, as the trial in a lawsuit filed by several municipalities got underway.
Blood clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU's drug watchdog said on Tuesday.
More reports, which have established link between AstraZeneca and Johnson & Johnson (J&J) vaccines with rare blood clotting disorder may fuel vaccine hesitancy and rejection in Nigeria.
There are growing concerns about the Johnson & Johnson coronavirus vaccine efficacy against coronavirus and its side effects. US health agencies Tuesday recommended an immediate pause in the rollout of the Johnson & Johnson coronavirus vaccine, according to a US Food and Drug Administration (FDA) statement released Tuesday. "Until that process is complete, we are…
The EU's drug regulator said Friday it had launched a review of possible links between the Johnson & Johnson coronavirus vaccine and blood clots after reports of four cases, one of them fatal.
South Africa's President Cyril Ramaphosa on Sunday said the country will start relaxing coronavirus restrictions, moving from alert level three down to level one
South Africa on Saturday received its second consignment of Johnson & Johnson Covid-19 vaccines, the health minister said, as the continent's hardest-hit country scrambles to shore up its inoculation drive.
European nations need to work more closely with drug firms to increase the pace of coronavirus inoculations, the WHO said on Friday, as Johnson & Johnson pushed for its jab to become the third approved for use in the United States.
5 Aug 2020
The US government Wednesday announced a new $1 billion investment in a COVID-19 vaccine being developed by Johnson & Johnson, guaranteeing 100 million doses.
5 Mar 2020
A consortium of philanthropic, non-profit and private sector organisations have launched a collaboration that aims to accelerate the development of novel “pan-TB” drug regimens
15 Dec 2018
In line with the theme Repositioning Healthcare in Africa for Sustainable Development, global brand Johnson & Johnson has announced the second edition of Africa...
16 May 2018
Pharmaceutical giant Johnson & Johnson announced on May 2, 208 that it would pay up to US$1 billion to acquire a company that makes cancer-killing viruses. It was a striking show of support for a still-unproven treatment, but the bid is just the latest sign that industry and academics are warming to the approach. In…